Commentary: GM1-Gangliosidosis Type III Associated Parkinsonism
Kurian M.A. Kaiyrzhanov R. Allahyarova P. Guliyeva U. Gulieva S. Salayev K. Mursalova A. Ferla M.P. Houlden H. Cardoso F.
August 2021John Wiley and Sons Inc
Movement Disorders Clinical Practice
2021#8Issue S1S24 - S25 pp.
Text of the article Перейти на текст статьи
Molecular Neurosciences, Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, United Kingdom
Department of Neurology, Great Ormond Street Hospital, London, United Kingdom
Department of Neuromuscular Disorders, Institute of Neurology, University College London, London, United Kingdom
Department of Neurology, South Kazakhstan Medical Academy, Shymkent, Kazakhstan
Department of Neurology, Azerbaijan Medical University, Baku, Azerbaijan
Bona Dea International Hospital, Baku, Azerbaijan
MediClub Hospital, Baku, Azerbaijan
NIHR Oxford BRC Genomic Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
Structural Genomics Consortium, University of Oxford, Oxford, United Kingdom
Movement Disorders Unit, Neurology Service, The Federal University of Minas Gerais, Belo Horizonte, Brazil
Molecular Neurosciences
Department of Neurology
Department of Neuromuscular Disorders
Department of Neurology
Department of Neurology
Bona Dea International Hospital
MediClub Hospital
NIHR Oxford BRC Genomic Medicine
Structural Genomics Consortium
Movement Disorders Unit
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026